Back
First Solar, Inc. Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Buy
78
FSLR
First Solar, Inc.
Last Price:
$270.38
Seasonality Move:
2.87%
Buy
60
ZBIO
Zenas BioPharma, Inc.
Last Price:
$41.96
Seasonality Move:
0.59%
Buy
78
First Solar, Inc. (FSLR)
is a Buy
Is First Solar, Inc. a Buy, Sell or Hold?
-
The current First Solar, Inc. [FSLR] share price is $284.59. The Score for FSLR is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
FSLR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Zenas BioPharma, Inc. (ZBIO)
is a Buy
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $42.33. The Score for ZBIO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ZBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FSLR Stock Price Chart
What is First Solar, Inc.'s stock price today?
-
The First Solar, Inc. share price today is $284.59Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FSLR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $42.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
FSLR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.89 | Buy |
| Relative Strength Index (14 RSI): | 64.82 | Buy |
| Chaikin Money Flow: | 3000150 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (251.38 - 268.36) | Buy |
| Bollinger Bands (100): | (201.46 - 258.4) | Buy |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.47 | Buy |
| Relative Strength Index (14 RSI): | 61.08 | Buy |
| Chaikin Money Flow: | 587345 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.32 - 39.82) | Buy |
| Bollinger Bands (100): | (17.72 - 34.64) | Buy |
FSLR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 263.68 | Buy |
| 20-day SMA: | 262.17 | Buy |
| 50-day SMA: | 254 | Buy |
| 200-day SMA: | 190.32 | Buy |
| 8-day EMA: | 265.96 | Buy |
| 20-day EMA: | 261.69 | Buy |
| 50-day EMA: | 251.58 | Buy |
| 200-day EMA: | 211.75 | Buy |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.46 | Buy |
| 20-day SMA: | 37.97 | Buy |
| 50-day SMA: | 33.51 | Buy |
| 200-day SMA: | 18.21 | Buy |
| 8-day EMA: | 24.11 | Buy |
| 20-day EMA: | 12.41 | Buy |
| 50-day EMA: | 5.54 | Buy |
| 200-day EMA: | 1.47 | Buy |
First Solar, Inc. Earnings Growth & FSLR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.43 per share, and an increase next year of $8.91 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.
First Solar, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||